Brevan Howard Capital Management LP Adaptive Biotechnologies Corp Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 60,213 shares of ADPT stock, worth $641,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,213
Previous 25,061
140.27%
Holding current value
$641,268
Previous $150,000
198.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$319 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$140 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$119 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$82.4 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.52B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...